ARTICLE | Company News
deCode, Roche deal
February 20, 2001 8:00 AM UTC
DCGN said it identified targets related to genes linked to schizophrenia and peripheral arterial occlusive disease (PAOD), triggering milestone payments from partner ROCZ. The companies will use the d...